Skip to content

Nodal fusion algorithm and survival mapping: an enhanced dynamic prognostication and treatment planning method in HCC patients

Nodal fusion algorithm and survival mapping: an enhanced dynamic prognostication and treatment planning method in HCC patients

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2400084721
Enrollment
Unknown
Registered
2024-05-23
Start date
2024-05-30
Completion date
Unknown
Last updated
2024-05-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

hepatocelluler carcinoma

Interventions

Interventional Therapy :None

Sponsors

Sun Yat-sen University Cancer Center
Lead Sponsor

Eligibility

Sex/Gender
All
Age
7 Years to 110 Years

Inclusion criteria

Inclusion criteria: a) Clinical or pathologically initial diagnosed hepatocellular carcinoma; b) The diagnosis and treatment process includes the use of comprehensive treatment, which includes interventional therapy; c) At the initial diagnosis, the ECOG PS score was 0 or 1; d) Before the first treatment, there should be a complete imaging report, blood test results (including biochemistry, blood routine, and tumor markers).

Exclusion criteria

Exclusion criteria: a) History of other malignant tumors within 5 years (excluding early stage basal cell carcinoma, cervical carcinoma in situ and Papillary thyroid carcinoma) b) ECOG PS score = 2; c) Child Pugh score = 7; Decompensation of liver function, such as the appearance of large amounts of ascites, gastric fundus and esophageal veins varicocephaly together with upper gastrointestinal bleeding within 1 year, hepatic encephalopathy and bilirubin encephalopathy.

Design outcomes

Primary

MeasureTime frame
Overall Survival;

Countries

China

Contacts

Public ContactWeijun Fan

Sun Yat-sen University Cancer Center

fanwj@sysucc.org.cn+86 135 6036 5452

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026